In the News

1861 News Items found
Dr. Helena Yu
Q&A
Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
A researcher working in an MSK lab
MSK research provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors.
MSK patient Aaron von Freter
MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.
Black male prostate cancer patient smiling.
Ask the Expert
Learn why Black men should be especially mindful of prostate cancer risk.
MSK surgeon-scientist Vinod Balachandran.
Article
Read about new findings on how tertiary lymphoid structures form to fight foreign threats such as cancer.
Adrienne Boire
Neuro-oncologist Dr. Adrienne Boire discusses her path to becoming a cancer researcher, and on the parallel between science and another passion — knitting.
Dr. Debyani Chakravarty
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
Luc Morris
Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.
Close-up of hand holding glass of red wine.
Learn more about the link between drinking alcohol and the risk of developing cancer.
Seungjae Lee and Eric Lai
New findings by researchers at MSK and their collaborators at the Icahn School of Medicine point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer.